Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

A protease storm cleaves a cell-cell adhesion molecule in cancer: multiple proteases converge to regulate PTPmu in glioma cells.

Phillips-Mason PJ, Craig SE, Brady-Kalnay SM.

J Cell Biochem. 2014 Sep;115(9):1609-23. doi: 10.1002/jcb.24824.

2.

Identification of phospholipase C gamma1 as a protein tyrosine phosphatase mu substrate that regulates cell migration.

Phillips-Mason PJ, Kaur H, Burden-Gulley SM, Craig SE, Brady-Kalnay SM.

J Cell Biochem. 2011 Jan;112(1):39-48. doi: 10.1002/jcb.22710.

3.

Protein tyrosine phosphatase mu regulates glioblastoma cell growth and survival in vivo.

Kaur H, Burden-Gulley SM, Phillips-Mason PJ, Basilion JP, Sloan AE, Brady-Kalnay SM.

Neuro Oncol. 2012 May;14(5):561-73. doi: 10.1093/neuonc/nos066. Epub 2012 Apr 14.

4.

Proteolytic cleavage of protein tyrosine phosphatase mu regulates glioblastoma cell migration.

Burgoyne AM, Phillips-Mason PJ, Burden-Gulley SM, Robinson S, Sloan AE, Miller RH, Brady-Kalnay SM.

Cancer Res. 2009 Sep 1;69(17):6960-8. doi: 10.1158/0008-5472.CAN-09-0863. Epub 2009 Aug 18.

5.

Furin-, ADAM 10-, and gamma-secretase-mediated cleavage of a receptor tyrosine phosphatase and regulation of beta-catenin's transcriptional activity.

Anders L, Mertins P, Lammich S, Murgia M, Hartmann D, Saftig P, Haass C, Ullrich A.

Mol Cell Biol. 2006 May;26(10):3917-34.

6.

A novel molecular diagnostic of glioblastomas: detection of an extracellular fragment of protein tyrosine phosphatase mu.

Burden-Gulley SM, Gates TJ, Burgoyne AM, Cutter JL, Lodowski DT, Robinson S, Sloan AE, Miller RH, Basilion JP, Brady-Kalnay SM.

Neoplasia. 2010 Apr;12(4):305-16.

7.

Single cell molecular recognition of migrating and invading tumor cells using a targeted fluorescent probe to receptor PTPmu.

Burden-Gulley SM, Qutaish MQ, Sullivant KE, Tan M, Craig SE, Basilion JP, Lu ZR, Wilson DL, Brady-Kalnay SM.

Int J Cancer. 2013 Apr 1;132(7):1624-32. doi: 10.1002/ijc.27838. Epub 2012 Oct 11.

8.

miR-221/222 overexpession in human glioblastoma increases invasiveness by targeting the protein phosphate PTPμ.

Quintavalle C, Garofalo M, Zanca C, Romano G, Iaboni M, del Basso De Caro M, Martinez-Montero JC, Incoronato M, Nuovo G, Croce CM, Condorelli G.

Oncogene. 2012 Feb 16;31(7):858-68. doi: 10.1038/onc.2011.280. Epub 2011 Jul 11.

9.

Protein tyrosine phosphatase receptor U (PTPRU) is required for glioma growth and motility.

Zhu Z, Liu Y, Li K, Liu J, Wang H, Sun B, Xiong Z, Jiang H, Zheng J, Hu Z.

Carcinogenesis. 2014 Aug;35(8):1901-10. doi: 10.1093/carcin/bgu123. Epub 2014 May 29.

11.

PTPmu suppresses glioma cell migration and dispersal.

Burgoyne AM, Palomo JM, Phillips-Mason PJ, Burden-Gulley SM, Major DL, Zaremba A, Robinson S, Sloan AE, Vogelbaum MA, Miller RH, Brady-Kalnay SM.

Neuro Oncol. 2009 Dec;11(6):767-78. doi: 10.1215/15228517-2009-019. Epub .

12.

Short-term TNFα shedding is independent of cytoplasmic phosphorylation or furin cleavage of ADAM17.

Schwarz J, Broder C, Helmstetter A, Schmidt S, Yan I, Müller M, Schmidt-Arras D, Becker-Pauly C, Koch-Nolte F, Mittrücker HW, Rabe B, Rose-John S, Chalaris A.

Biochim Biophys Acta. 2013 Dec;1833(12):3355-67. doi: 10.1016/j.bbamcr.2013.10.005. Epub 2013 Oct 14.

13.

ADAM12 is selectively overexpressed in human glioblastomas and is associated with glioblastoma cell proliferation and shedding of heparin-binding epidermal growth factor.

Kodama T, Ikeda E, Okada A, Ohtsuka T, Shimoda M, Shiomi T, Yoshida K, Nakada M, Ohuchi E, Okada Y.

Am J Pathol. 2004 Nov;165(5):1743-53.

14.

L1 stimulation of human glioma cell motility correlates with FAK activation.

Yang M, Li Y, Chilukuri K, Brady OA, Boulos MI, Kappes JC, Galileo DS.

J Neurooncol. 2011 Oct;105(1):27-44. doi: 10.1007/s11060-011-0557-x. Epub 2011 Mar 4.

15.

In vivo cleaved CDCP1 promotes early tumor dissemination via complexing with activated β1 integrin and induction of FAK/PI3K/Akt motility signaling.

Casar B, Rimann I, Kato H, Shattil SJ, Quigley JP, Deryugina EI.

Oncogene. 2014 Jan 9;33(2):255-68. doi: 10.1038/onc.2012.547. Epub 2012 Dec 3.

16.

Relevance of IGFBP2 proteolysis in glioma and contribution of the extracellular protease ADAMTS1.

Martino-Echarri E, Fernández-Rodríguez R, Bech-Serra JJ, Plaza-Calonge Mdel C, Vidal N, Casal C, Colomé N, Seoane J, Canals F, Rodríguez-Manzaneque JC.

Oncotarget. 2014 Jun 30;5(12):4295-304.

17.

Tumor suppressor cell adhesion molecule 1 (CADM1) is cleaved by a disintegrin and metalloprotease 10 (ADAM10) and subsequently cleaved by γ-secretase complex.

Nagara Y, Hagiyama M, Hatano N, Futai E, Suo S, Takaoka Y, Murakami Y, Ito A, Ishiura S.

Biochem Biophys Res Commun. 2012 Jan 6;417(1):462-7. doi: 10.1016/j.bbrc.2011.11.140. Epub 2011 Dec 7.

PMID:
22172944
18.

Girdin, an actin-binding protein, is critical for migration, adhesion, and invasion of human glioblastoma cells.

Gu F, Wang L, He J, Liu X, Zhang H, Li W, Fu L, Ma Y.

J Neurochem. 2014 Nov;131(4):457-69. doi: 10.1111/jnc.12831. Epub 2014 Aug 12.

19.
20.

Functional comparison of long and short splice forms of RPTPbeta: implications for glioblastoma treatment.

Lorente G, Nelson A, Mueller S, Kuo J, Urfer R, Nikolich K, Foehr ED.

Neuro Oncol. 2005 Apr;7(2):154-63.

Items per page

Supplemental Content

Write to the Help Desk